Foresight Diagnostics, Inc.
- Diagnostics
- Biotech or pharma, therapeutic R&D
Foresight Diagnostics Inc. is a pioneering cancer diagnostics company focused on developing ultra-sensitive liquid biopsy tests for minimal residual disease (MRD) detection. Founded in 2020 by physicians and scientists from Stanford University, the company aims to revolutionize cancer management by providing more accurate and actionable data to physicians and biopharmaceutical companies. Headquartered in Boulder, Colorado, Foresight Diagnostics operates a CLIA-registered laboratory with automated, scalable testing capabilities.
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}
){kind=logo}